 Shares of small-cap penny stock Adial Pharmaceuticals, Inc. NASDAQ: ADIL shares are trading about 20.5 lower at 1.46 per share Wednesday morning. The company announced topline results for its Onward Phase 3 trial for AD04 in patients with Alcohol Use Disorder. 